Researchers identify genetic marker that could guide brain cancer treatment

UK researchers identify biomarkers indicating certain patients may be more likely to benefit from cancer drug

University of Kentucky Markey Cancer Center researchers report they have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.

Researchers identify genetic marker that could guide brain cancer treatment

University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.